您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL COMPOSITION COMPRISING GINSENG EXTRACTS FOR PREVENTION AND TREATMENT OF OPHTHALMOLOGICAL DISEASES
专利权人:
GINTONIN KU BIOTECH Co.; Ltd.
发明人:
Seung-Yeol NAH,Joon-Young KIM,Hyeon-Joong KIM,Seok-Won JUNG
申请号:
US15453417
公开号:
US20180256677A1
申请日:
2017.03.08
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Provided is a treatment composition for damage treatment and regeneration promotion of corneal epithelial cells containing gintonin as an active ingredient which is glycolipoprotein or its aggregate isolated from ginseng. Since the gintonin as a drug containing high-concentration LPA has an effect of increasing the concentration of LPA in damaged cornea and inducing the proliferation of corneal epithelial cells to rapidly and significantly restore the damage of the cornea, the composition of the present disclosure can be usefully used as drugs for treatment of corneal erosion and corneal ulcer or equivalent therapeutic agents for corneal injury in humans and animals.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充